GHRH Receptor Signalling
CJC-1295 no DAC is investigated in experimental systems examining activation of growth hormone-releasing hormone receptor pathways.
UK StockedReady to ship
Same-Day DispatchOrders placed before 2pm
Free Tracked 24On orders over £25
Compound overview
CJC-1295 no DAC + Ipamorelin is a dual-peptide research formulation combining CJC-1295 without DAC, a modified growth hormone-releasing hormone (GHRH) analogue, with Ipamorelin, a selective ghrelin-receptor agonist.
Each vial contains 10mg total — 5mg CJC-1295 no DAC + 5mg Ipamorelin — supplied as a lyophilised blend for controlled in vitro laboratory research.
At a glance
Blend type Dual-peptide research blend
Vial content 10MG
Components 2 compounds
Format Lyophilised blend
Research focus
Ghrelin Receptor Activity
Ipamorelin is studied in relation to selective activity at the ghrelin receptor and associated intracellular signalling mechanisms.
Receptor-Mediated Signalling
The blend is used in models examining downstream cellular responses associated with GHRH and ghrelin receptor activation.
Endocrine Signalling Models
Studied in experimental systems investigating peptide-mediated endocrine signalling and regulatory feedback pathways.
Key features
- Third-party HPLC tested
- 10mg total blend per vial
- Typically 5mg CJC-1295 no DAC + 5mg Ipamorelin
- Dual-peptide formulation
- GHRH and ghrelin receptor research profile
- Stable lyophilised format
- UK stocked
View full research overview
CJC-1295 no DAC + Ipamorelin is a dual-peptide research formulation combining CJC-1295 without DAC, a modified growth hormone-releasing hormone (GHRH) analogue, with Ipamorelin, a selective ghrelin-receptor agonist.
Each vial contains 10mg total — 5mg CJC-1295 no DAC + 5mg Ipamorelin — supplied as a lyophilised blend for controlled in vitro laboratory research.
The two compounds are used in experimental studies examining distinct but related receptor systems. CJC-1295 no DAC is investigated in relation to GHRH receptor signalling, while Ipamorelin is studied for its activity at the ghrelin receptor (GHSR). The combined formulation allows researchers to examine interactions between these signalling pathways within the same experimental system.
Key Features
- Third-party HPLC tested
- 10mg total blend per vial
- Typically 5mg CJC-1295 no DAC + 5mg Ipamorelin
- Dual-peptide formulation
- GHRH and ghrelin receptor research profile
- Stable lyophilised format
- UK stocked
Area of Interest
Laboratory research involving CJC-1295 no DAC and Ipamorelin has examined several receptor and endocrine signalling mechanisms:
- GHRH Receptor Signalling: CJC-1295 no DAC is investigated in experimental systems examining activation of growth hormone-releasing hormone receptor pathways.
- Ghrelin Receptor Activity: Ipamorelin is studied in relation to selective activity at the ghrelin receptor and associated intracellular signalling mechanisms.
- Receptor-Mediated Signalling: The blend is used in models examining downstream cellular responses associated with GHRH and ghrelin receptor activation.
- Endocrine Signalling Models: Studied in experimental systems investigating peptide-mediated endocrine signalling and regulatory feedback pathways.
- Dual-Peptide Interaction: Used to examine complementary, overlapping, or interacting effects between GHRH analogue and ghrelin-receptor signalling.
Together, these areas make CJC-1295 no DAC + Ipamorelin a dual-component formulation of interest for in vitro research into receptor signalling, peptide interactions, endocrine pathways, and cellular response mechanisms.
For in vitro laboratory research only. Not for human or veterinary use.
| Contents | CJC-1295 (no DAC) 5 mg + Ipamorelin 5 mg (total 10 mg) |
| Form | Lyophilized white powder |
| Purity | ≥98% for each peptide (HPLC verified) |
| Appearance | White to off-white lyophilized cake |
| Storage (lyophilized) | Refrigerate at 2–8°C; for long-term storage, freeze at −20°C. |
Lyophilized Storage
Store refrigerated at 2–8°C. For long-term storage, store frozen at −20°C. Keep sealed and protected from light and moisture.
⚠ For in vitro laboratory research only. Not for human or veterinary use.
CJC-1295 / IPAMORELIN
10MG
Limited-time price
Original price was: £44.95.£39.95Current price is: £39.95.-11%
Calculating dispatch time...
In Stock · UK dispatch
For in vitro laboratory research only. Not for human or veterinary use.
Third-party tested Free Tracked 24 over £25 Secure checkout
